VARUNA
The VARUNA on-line self assessment platform has the objectives to: quantify GCP compliance in HIV care across Europe, identify RT tools routinely used in clinical practice across Europe, analyse it by geography as well as to use self-assessment as a strategy for promotion of GCP compliance What do you have to do? The self-assessment will […]
CARE
The overall objective of CARE Common Action aganist HIV/TB/HCV Acoss the Region of Europe is to analyse and combat the human immunodeficiency virus (HIV), tuberculosis (TB) and hepatitis C (HCV) epidemics across the European Region with a specific focus on the Russian Federation, through the establishment and expansion of previously created EU-Russian networks. The consortium […]
MDR
The MDR project (HIV multidrug resistance pathways in the EuResist Integrated DataBase) aims at estimating the prevalence and trend over time of MDR (multidrug resistance) in HIV patients, using descriptive statistics, retaining high value because of the large sample size and wide representativeness of the EIDB. In addition, the project aims at identifying factors associated […]
Integrate
The INTEGRATE project aims at building and maintaining a large, curated collection of virological and clinical data to increase scientific knowledge on resistance to integrase strand transfer inhibitors (InSTI) and on the most appropriate use of this class of antiretroviral agents. The project takes advantage of the EuResist Network structure and expertise to manage the […]
EuResist Mentor School
EuResist Network has launched an educational activity finalised to train young physicians and biologists in dealing with structured data (databases). The overall objectives of the initiative are to nurture a generation of scientists able to bridge the gap among medical/biological sciences and IT data management/statistics and to exploit at best the potential of structured collections […]
New publication “Data privacy, data property and data sharing” in post-pandemic research
The book on “Data privacy, data property and data sharing” was published by Routledge on 16 December 2025.This publication addresses the controversial issues surrounding data sharing, including data protection, ownership and reuse, and the related ethical considerations, answering the “cahier de doleance” arising from biomedical research with data. Edited by Mariavittoria Catanzariti, Francesca Incardona, Giorgio […]
EuResist Network Joins Key Bilateral Event in China
EuResist Network has been selected to participate in the XIV China-Italy Science, Technology, and Innovation Week. This prestigious event for scientific and technological cooperation, is organized under the auspices of the Italian Ministry of University and Research and the Chinese Ministry of Science and Technology.The Week, scheduled from November 13 to November 20, 2025, in […]
CARE4ART results presented at the 20th European AIDS Conference
EuResist Network GEIE was at the 20th European AIDS Conference for insights on INSTI resistance in people with HIV-1A6!A poster detailing results from the @EuResist CARE4ART international study is now at the 20th European AIDS Conference in Paris (October 15-18, 2025). Dr. Maarten van de Klundert is presenting: “Analysis of viral load and INSTI resistance […]
EuResist Celebrates EU Day at the AREVIR meeting with a focus on Collaborative EU Project
Today, May 9th, marks EU Day, a celebration of European cooperation and unity. Here at EuResist, we’re proud to embody this spirit through our active participation in impactful EU-funded projects. To mark the occasion, Francesca Incardona attended the AREVIR meeting in Cologne by sharing insights into the three EU projects that EuResist is involved in. […]
Rome Hosts Successful Launch of VIROMARKERS Project
The VIROMARKERS project, started on February 1, 2025, celebrated its official launch with a dynamic kickoff meeting in Rome on April 3rd and 4th, 2025. The event fostered lively scientific discussions within a friendly and collaborative setting, signaling an exciting start for the consortium. Driven by a shared goal, VIROMARKERS will focus on developing groundbreaking […]